Aramis Site 123 — Cranberry Township, Pennsylvania

Aramis Site 123 is a clinical research site located in Cranberry Township, Pennsylvania, United States 16066.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Aramis Site 123 has participated in 1 clinical trials.

Therapeutic areas: Dry Eye Disease.

Sponsors: Aramis Biosciences, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cranberry Township

Browse all research sites in Pennsylvania · View every site in Cranberry Township

• Magee-Womens Hospital of UPMC,3 St. Francis Way
• Children's Community Pediatrics (CCP-Bass Wolfson Cranberry) of Children's Hospital of Pittsburgh of UPMC
• Scott Christie and Associates PC
• UPMC Hillman Cancer Center - Passavant - Cranberry
• Scott Christie and Associates
• CYS-005 Investigational Site
• Ocular Therapeutix, Inc.
• GSK Investigational Site
• Orasis Investigative Site
• UPMC Hillman Cancer Center Passavant North
• Pfizer Investigational Site
• UPMC Magee at the Lemieux Sports Complex

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Aramis Site 123?

Aramis Site 123 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Aramis Site 123 conducted?

Aramis Site 123 has 1 clinical trials on record. Their work covers Dry Eye Disease.

Is Aramis Site 123 accredited by Crixeo Clinical Trials?

Aramis Site 123 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Aramis Site 123?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.